Related references
Note: Only part of the references are listed.Structural modification aimed for improving solubility of lead compounds in early phase drug discovery
Bhanuranjan Das et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2022)
Discovery solubility measurement and assessment of small molecules with drug development in mind
Jaclyn A. Barrett et al.
DRUG DISCOVERY TODAY (2022)
Synthesis and Structure-Activity Relationships of Novel Non-Steroidal CYP17A1 Inhibitors as Potential Prostate Cancer Agents
Tomasz M. Wrobel et al.
BIOMOLECULES (2022)
Importance of Asparagine 202 in Manipulating Active Site Structure and Substrate Preference for Human CYP17A1
Yilin Liu et al.
BIOCHEMISTRY (2022)
The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancer
Chetan Padmakar Darne et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)
Crystal Structure of CYP3A4 Complexed with Fluorol Identifies the Substrate Access Channel as a High-Affinity Ligand Binding Site
Irina F. Sevrioukova
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Target-specific compound selectivity for multi-target drug discovery and repurposing
Tianduanyi Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Generation of new inhibitors of selected cytochrome P450 subtypes- In silico study
Tomasz Danel et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
Frontiers of metal-coordinating drug design
Giulia Palermo et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
The role of androgen and its related signals in PCOS
Wenting Ye et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Substrate-Specific Allosteric Effects on the Enhancement of CYP17A1 Lyase Efficiency by Cytochrome b5
Yilin Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Steroidogenic cytochrome P450 17A1 structure and function
Sarah D. Burris-Hiday et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)
Stepwise binding of inhibitors to human cytochrome P450 17A1 and rapid kinetics of inhibition of androgen biosynthesis
F. Peter Guengerich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Tight binding of cytochrome b5 to cytochrome P450 17A1 is a critical feature of stimulation of C21 steroid lyase activity and androgen synthesis
Donghak Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
New benzothieno[2,3-c]pyridines as non-steroidal CYP17 inhibitors: design, synthesis, anticancer screening, apoptosis induction, and in silico ADME profile studies
Nadia A. Khalil et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase Inhibitors
Brendan T. Parr et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review
Raffaele Ratta et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Multistep Binding of the Non-Steroidal Inhibitors Orteronel and Seviteronel to Human Cytochrome P450 17A1 and Relevance to Inhibition of Enzyme Activity
Stella A. Child et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Benjamin M. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
Tomasz M. Wrobel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Comparative Dynamics and Functional Mechanisms of the CYP17A1 Tunnels Regulated by Ligand Binding
Fei Xiao et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
FABP5 as a novel molecular target in prostate cancer
Saoirse Elizabeth O'Sullivan et al.
DRUG DISCOVERY TODAY (2020)
Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer
Zohaib Rana et al.
BIOMEDICINES (2020)
Targeting Metalloenzymes for Therapeutic Intervention
Allie Y. Chen et al.
CHEMICAL REVIEWS (2019)
Alternative (backdoor) androgen production and masculinization in the human fetus
Peter J. O'Shaughnessy et al.
PLOS BIOLOGY (2019)
Conformational selection dominates binding of steroids to human cytochrome P450 17A1
F. Peter Guengerich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The backdoor pathway of androgen synthesis in human male sexual development
Walter L. Miller et al.
PLOS BIOLOGY (2019)
The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors
Jingxiang Zhang et al.
FRONTIERS IN MICROBIOLOGY (2019)
Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research
Liyu Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Structural analysis of Cytochrome P450 BM3 mutant M11 in complex with dithiothreitol
Karla Frydenvang et al.
PLOS ONE (2019)
Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway
Patricia Rodriguez Castano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CYP17A1 Maintains the Survival of Glioblastomas by Regulating SAR1-Mediated Endoplasmic Reticulum Health and Redox Homeostasis
Hong-Yi Lin et al.
CANCERS (2019)
Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17α-hydroxylase-C17,20-lyase (Cyp17)
Benjamin E. Blass et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Accelerated skin wound healing by selective 11β-Hydroxylase (CYP11B1) inhibitors
Juliette Emmerich et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Estrogen therapy in patients with prostate cancer: a contemporary systematic review
Leonardo Oliveira Reis et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2018)
HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer
Mohammad Alyamani et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2
Charlie Fehl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Human Cytochrome CYP17A1: The Structural Basis for Compromised Lyase Activity with 17-Hydroxyprogesterone
Piotr J. Mak et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency
Monica Fernandez-Cancio et al.
PHARMACEUTICALS (2018)
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Jemilat Salami et al.
COMMUNICATIONS BIOLOGY (2018)
Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles
David T. Hoang et al.
ONCOTARGET (2017)
Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels
Ronald S. Swerdloff et al.
ENDOCRINE REVIEWS (2017)
Discovery of novel 1,2,3,4-tetrahydrobenzo[4,5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors
Mingliang Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Mechanism of Cytochrome P450 17A1-Catalyzed Hydroxylase and Lyase Reactions
Silvia Bonomo et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Role of cytochrome b5 in the modulation of the enzymatic activities of cytochrome P450 17α-hydroxylase/17,20-lyase (P450 17A1)
Megh Raj Bhatt et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2
Jana Malikova et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Structural insights into the function of steroidogenic cytochrome P450 17A1
Rahul Yadav et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Dose considerations for anti-cancer drugs in metastatic prostate cancer
Megan Crumbaker et al.
PROSTATE (2017)
Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma
J-Y Chuang et al.
ONCOGENESIS (2017)
A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome
Elena Valassi et al.
CLINICAL ENDOCRINOLOGY (2017)
Structural and Functional Evaluation of Clinically Relevant Inhibitors of Steroidogenic Cytochrome P450 17A1
Elyse M. Petrunak et al.
DRUG METABOLISM AND DISPOSITION (2017)
Thermodynamics of interactions between mammalian cytochromes P450 and b5
Evgeny Yablokov et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR
D. Fernando Estrada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer
Audris Huang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Evidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen synthesis
Ruchia Duggal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis
Sameer S. Udhane et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Design, synthesis, and evaluation of (2S, 4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome
Benjamin E. Blass et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Membrane-Anchored Cytochrome P450 1A2-Cytochrome b5 Complex Features an X-Shaped Contact between Antiparallel Transmembrane Helices
Petr Jerabek et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Guillemette E. Benoist et al.
CLINICAL PHARMACOKINETICS (2016)
The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature
Ian M. Bird et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors
Silvia Bonomo et al.
SCIENTIFIC REPORTS (2016)
ASN001, a novel CYP17 lyase inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC): Safety/tolerability and early activity in a multicenter phase 1/2 trial
Niranjan Sathyanarayana Rao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1)
Francis K. Yoshimoto et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Relationship between CYP17A1 genetic polymorphism and coronary artery disease in a Chinese Han population
Chuan-Fang Dai et al.
LIPIDS IN HEALTH AND DISEASE (2015)
Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors
Stephen W. Rafferty et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Retinoic acid regulation by CYP26 in vertebrate lens regeneration
Alvin G. Thomas et al.
DEVELOPMENTAL BIOLOGY (2014)
Risk for estrogen-dependent diseases in relation to phthalate exposure and polymorphisms of CYP17A1 and estrogen receptor genes
Po-Chin Huang et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2014)
Roles for the Backdoor Pathway of Androgen Metabolism in Prostate Cancer Response to Castration and Drug Treatment
Michael V. Fiandalo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Catalytically Relevant Electrostatic Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b5
Hwei-Ming Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Human Cytochrome P450 17A1 Conformational Selection
D. Fernando Estrada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Structures of Human Steroidogenic Cytochrome P450 17A1 with Substrates
Elyse M. Petrunak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
Francisco E. Vera-Badillo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Adrenal Androgens and Androgen Precursors-Definition, Synthesis, Regulation and Physiologic Actions
Adina Turcu et al.
COMPREHENSIVE PHYSIOLOGY (2014)
Phosphorylation of Human Cytochrome P450c17 by p38α Selectively Increases 17,20 Lyase Activity and Androgen Biosynthesis
Meng Kian Tee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Substrate-modulated Cytochrome P450 17A1 and Cytochrome b75 Interactions Revealed by NMR
D. Fernando Estrada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Highly Potent and Selective Nonsteroidal Dual Inhibitors of CYP17/CYP11B2 for the Treatment of Prostate Cancer To Reduce Risks of Cardiovascular Diseases
Mariano A. E. Pinto-Bazurco Mendieta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats
Takahito Hara et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
On the Measurement of Solubility
Simon Black et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2013)
Current and emerging treatments in the management of castration-resistant prostate cancer
David Shapiro et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Variants in CYP17 and CYP19 Cytochrome P450 Genes are Associated with Onset of Alzheimer's Disease in Women with Down Syndrome
Constance Chace et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Modeling Androgen Receptor Flexibility: A Binding Mode Hypothesis of CYP17 Inhibitors/Antiandrogens for Prostate Cancer Therapy
Eleonora Gianti et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Novel Imidazol-1-ylmethyl Substituted 1,2,5,6-Tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as Potent and Selective CYP11B1 Inhibitors for the Treatment of Cushing's Syndrome
Lina Yin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001
Natasha M. DeVore et al.
NATURE (2012)
Synthesis and biological evaluation of imidazolylmethylacridones as cytochrome P-450 enzymes inhibitors
Ashraf H. Abadi et al.
MEDCHEMCOMM (2012)
17,20-Lyase inhibitors. Part 3: Design, synthesis, and structure-activity relationships of biphenylylmethylimidazole derivatives as novel 17,20-lyase inhibitors
Tomohiro Kaku et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
17,20-Lyase inhibitors. Part 4: Design, synthesis and structure-activity relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase inhibitors
Tomohiro Kaku et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer
Tomohiro Kaku et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
Changmeng Cai et al.
CANCER RESEARCH (2011)
The effects of nitrogen-heme-iron coordination on substrate affinities for cytochrome P450 2E1
Jeffrey P. Jones et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Walter L. Miller et al.
ENDOCRINE REVIEWS (2011)
Quantitatively Interpreted Enhanced Inhibition of Cytochrome P450s by Heteroaromatic Rings Containing Nitrogen
Andrew G. Leach et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Design, Synthesis, and Biological Evaluation of Imidazolyl Derivatives of 4,7-Disubstituted Coumarins as Aromatase Inhibitors Selective over 17-α-Hydroxylase/C17-20 Lyase
Angela Stefanachi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Temperature-Dependent Spin Crossover in Neuronal Nitric Oxide Synthase Bound with the Heme-Coordinating Thioether Inhibitors
Tzanko Doukov et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Design and synthesis of 1,3,5-trisubstituted 1,2,4-triazoles as CYP enzyme inhibitors
Yaseen A. Al-Soud et al.
TETRAHEDRON LETTERS (2011)
Steroid Profiling by Gas Chromatography–Mass Spectrometry and High Performance Liquid Chromatography–Mass Spectrometry for Adrenal Diseases
Jeffrey G. McDonald et al.
Hormones & Cancer (2011)
Alkyl Isocyanides Serve as Transition State Analogues for Ligand Entry and Exit in Myoglobin
George C. Blouin et al.
BIOCHEMISTRY (2010)
Synthesis and biochemical evaluation of a range of (4-substituted phenyl) sulfonate derivatives of 4-hydroxybenzyl imidazole-based compounds as potent inhibitors of 17α-hydroxylase/17,20-lyase (P45017α) derived from rat testicular microsomes
Caroline P. Owen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
Francesca De Amicis et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
The Role of Fluorine Substitution in Biphenyl Methylene Imidazole-Type CYP17 Inhibitors for the Treatment of Prostate Carcinoma
Qingzhong Hu et al.
CHEMMEDCHEM (2010)
Impact of Differential P450c17 Phosphorylation by cAMP Stimulation and by Starvation Conditions on Enzyme Activities and Androgen Production in NCI-H295R Cells
Petra Kempna et al.
ENDOCRINOLOGY (2010)
Isopropylidene Substitution Increases Activity and Selectivity of Biphenylmethylene 4-Pyridine Type CYP17 Inhibitors
Qingzhong Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Replacement of Imidazolyl by Pyridyl in Biphenylmethylenes Results in Selective CYP17 and Dual CYP17/CYP11B1 Inhibitors for the Treatment of Prostate Cancer
Qingzhong Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Molecular Modeling on Inhibitor Complexes and Active-Site Dynamics of Cytochrome P450 C17, a Target for Prostate Cancer Therapy
Shozeb M. Haider et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Heme-Coordinating Inhibitors of Neuronal Nitric Oxide Synthase. Iron-Thioether Coordination Is Stabilized by Hydrophobic Contacts without Increased Inhibitor Potency
Jeffrey D. Martell et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Synthesis and biochemical evaluation of a range of sulfonated derivatives of 4-hydroxybenzyl imidazole as highly potent inhibitors of rat testicular 17α-hydroxylase/17,20-lyase (P-45017α)
Sabbir Ahmed et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Steroidogenic cytochrome P450 (CYP) enzymes as drug targets: Combining substructures of known CYP inhibitors leads to compounds with different inhibitory profile
Ulrike E. Hille et al.
COMPTES RENDUS CHIMIE (2009)
Novel CYP17 inhibitors: Synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls
Ulrike E. Hille et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
CYP17 Inhibitors. Annulations of Additional Rings in Methylene Imidazole Substituted Biphenyls: Synthesis, Biological Evaluation and Molecular Modelling
Mariano A. E. Pinto-Bazurco Mendieta et al.
ARCHIV DER PHARMAZIE (2008)
Synthesis, biological evaluation, and molecular modeling studies of methylene imidazole substituted biaryls as inhibitors of human 17α-hydroxylase-17,20-lyase (CYP17) -: Part II:: Core rigidification and influence of substituents at the methylene bridge
Qingzhong Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17α-hydroxylase-17,20-lyase (CYP17).: Part I:: Heterocyclic modifications of the core structure
Carsten Jagusch et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17
Mariano A. E. Pinto-Bazurco Mendieta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Simultaneous Measurement of Serum Testosterone and Dihydrotestosterone by Liquid Chromatography-Tandem Mass Spectrometry
Steve Shiraishi et al.
CLINICAL CHEMISTRY (2008)
Metabolic evidence for impaired 17α-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17,20-lyase activity
Dov Tiosano et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: Novel CYP17 inhibitors for the treatment of prostate cancer
Mariano A. E. Pinto-Bazurco Mendieta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17α-hydroxlase/17,20-lyase (P45017α)
Caroline P. Owen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Synthesis, biochemical evaluation of a range of potent 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17α-hydroxylase/17,20-Lyase (P45017α)
Imran Shahid et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Plasma testosterone and prognosis of postmenopausal breast cancer patients
Andrea Micheli et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Inhibition of 17 alpha-Hydroxylase/C-17,(20)-Lyase (CYP17) from rat testis by green tea catechins and black tea theaflavins
Ken-ichi Kimura et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2007)
Simultaneous determination of androstenedione and testosterone in human serum by liquid chromatography-tandem mass spectrometry
L. M. Gallagher et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2007)
Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17α-hydroxylase/17,20-lyase (P45017α)
Chirag H. Patel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Synthesis and biochemical evaluation of a range of potent benzyl imidazole-based compounds as potential inhibitors of the enzyme complex 17α-hydroxylase/17,20-lyase (P45017α)
Caroline P. Owen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Selective optimization of side activities: the SOSA approach
CG Wermuth
DRUG DISCOVERY TODAY (2006)
Cytochrome b5 modulation of 17α hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis
MK Akhtar et al.
JOURNAL OF ENDOCRINOLOGY (2005)
Heteroaryl-substituted naphthalenes and structurally modified derivatives:: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosis
M Voets et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Minireview: Regulation of steroidogenesis by electron transfer
WL Miller
ENDOCRINOLOGY (2005)
Synthesis of hydroxy derivatives of highly potent non-steroidal CYP 17 inhibitors as potential metabolites and evaluation of their activity by a non cellular assay using recombinant human enzyme
TU Hutschenreuter et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2004)
C17,20-lyase inhibitors.: Part 2:: Design, synthesis and structure-activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitors
N Matsunaga et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Adrenocortical cell lines
WE Rainey et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
The backdoor pathway to dihydrotestosterone
RJ Auchus
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
The cationic charges on Arg347, Arg358 and Arg449 of human cytochrome P450c17 (CYP17) are essential for the enzyme's cytochrome b5-dependent acyl-carbon cleavage activities
P Lee-Robichaud et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
C17,20-lyase inhibitors I.: Structure-based de novo design and SAR study of C17,20-lyase inhibitors
N Matsunaga et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy
OO Clement et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
5α-androstane-3α,17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α,17α-diol-20-one as a key intermediate
JD Wilson et al.
ENDOCRINOLOGY (2003)
Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-α gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women
I Gorai et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
N-(4-biphenylmethyl)imidazoles as potential therapeutics for the treatment of prostate cancer: Metabolic robustness due to fluorine substitution?
F Leroux et al.
HELVETICA CHIMICA ACTA (2003)
Automated chromatographic system for the simultaneous measurement of plasma pregnenolone and 17-hydroxypregnenolone by radioimmunoassay
FG Riepe et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2001)
Urinary steroid profile analysis
JW Honour
CLINICA CHIMICA ACTA (2001)
A new class of nonsteroidal aromatase inhibitors:: Design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17α-hydroxylase/C17,20-lyase
M Recanatini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Novel imidazolyl and triazolyl substituted biphenyl compounds:: Synthesis and evaluation as nonsteroidal inhibitors of human 17α-hydroxylase-C17, 20-lyase (P450 17)
Y Zhuang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2000)
Share Paper
